Waiting
Traitement de la connexion…

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Genetics / Systemic Delivery of MicroRNA Using Recombinant…
JoVE Journal
Genetics

Ce contenu est en libre accès.

JoVE Journal Genetics
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
 

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Article DOI: 10.3791/55724-v • 06:51 min • August 10th, 2018
August 10th, 2018 •
1, 2, 1, 1, 1,3, 1, 1,4
1Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 2Section on Nervous System Development and Plasticity, The Eunice Kennedy Shriver National Institute of Child and Human Development, National Institutes of Health, 3Department of Molecular Biosciences, Rice Institute for Biomedical Research, Northwestern University, 4Department of Physiology, Anatomy and Genetics, University of Oxford

Chapitres

résumé
Automatic Translation

Here we describe the delivery of microRNA using a recombinant adeno-associated virus serotype 9 in a mouse model of a neuromuscular disease. A single peripheral administration in mice resulted in sustained miRNA overexpression in muscle and motor neurons, providing an opportunity to study miRNA function and therapeutic potential in vivo.

Tags

Systemic Delivery MicroRNA Recombinant Adeno-associated Virus Serotype 9 Neuromuscular Diseases Rodents Skeletal Muscle Motor Neurons Efficacy Disease Phenotypes Silencing Strategy Adeno-associated Serotype 9 Virus Spinal Cord Viral Load Plasmid Stock Aliquots Genomes Per Milliliter Syringe Needle Mouse Restrainer Tail Vein Bevel Up Shallow Angle Injection Bleeding
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter